Articles On Resapp Health (ASX:RAP)

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week With stock...

The ResApp Health Ltd (ASX: RAP) share price has returned from its trading halt and sunk lower. At the time of writing, the digital health company’s shares are down 9% to 6.2 cents. Why was the ResApp share price in a trading halt? ResApp...

Small caps have gained for a sixth straight day, even as their larger peers declined. The Small Ordinaries index of Australia’s 101st to 300th biggest companies finished the week up 6.7 points, or 0.2 per cent, to a fresh 13-year high of 3,...

The ASX rose for the fifth day in a row with resources leading the charge. The ASX 200 gained 1.02 per cent closing at 6,999 points while the ASX Emerging Companies Index rose by 0.63 per cent to 2,059. All sectors were in the green but res...

Source: G-Stock Studio, Shutterstock On Thursday, the market continued its gaining spree. The benchmark index ASX 200 has maintained yesterday's growth momentum. All sectors traded higher today, with Financial leading the gains, followed b...

Morgans analyst Iain Wilkie speaks with Chief Executive Officer and Managing Director of ResApp (ASX:RAP), Tony Keating. Tony provides an update on a number of recent news events.

If you want to know which ASX stocks fund managers and famous investors are putting their money into we’ve been keeping track of substantial holder buys (and sells). Trading Places is Stockhead’s recap of the substantial holder movements am...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

The S&P/ASX 200 Index (ASX: XJO) is out of form on Wednesday and sinking lower. In afternoon trade, the benchmark index is down a disappointing 0.75% to 6,775.9 points. Four ASX shares that are falling more than most today are listed b...

The Resapp Health Ltd (ASX: RAP) share price is soaring today. ResApp shares are up 8.33% at the time of writing to 7.8 cents a share. The company closed at a price of 7.2 cents yesterday but opened at 7.3 cents this morning before rising...

Source: dindumphoto,Shutterstock Summary ResApp has won a licensing deal from AstraZeneca’s Japanese subsidiary for its cough counting technology. As part of the agreement, ResApp’s technology will be integrated into the asthma manage...

ASX medtech play ResApp Health (ASX:RAP) has made further progress on the commercialisation of its medical respiratory technology, announcing today that ... Read More The post ResApp signs second deal with AstraZeneca, sending share price h...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) has followed the lead of US markets and is trading notably higher. At the time of writing, the benchmark index is up 0.8% to 6,765.3 points. Four ASX shares that are climbing more...

The ResApp Health Ltd (ASX: RAP) share price is surging higher after releasing its second announcement in as many days. You can read about the first announcement here. At the time of writing, the digital health company’s shares are up 19%...

Source: Guschenkova ,Shutterstock Summary ResApp to develop a smartphone-based algorithm to identify COVID-19 by using cough sound. The Company is confident that the sound identification of COVID-19 will significantly reinforce its of...

The ResApp Health Ltd (ASX: RAP) share price is surging higher on Thursday. In morning trade the digital health company’s shares are up 5% to 6 cents. Why is the ResApp share price surging higher? Investors have been buying ResApp shares o...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) has given back its early gains and is tumbling lower. At the time of writing, the benchmark index is down 0.2% to 6,699.7 points. Four ASX shares that are not letting that hold the...

The ResApp Health Ltd (ASX: RAP) share price is sinking today. This comes after the company announced that Medgate had started European trails for ResAppDx, its smartphone-based acute respiratory diagnostic test. At the time of writing, th...

Shares in ResApp Health Ltd (ASX: RAP) surged higher on open today after the company announced its wearable device has achieved CE mark certification. In early trade, the ResApp share price leapt 10.53% to 6.3 cents. However, at the time o...

Source: PHOTOBUAY,Shutterstock Emyria Limited (ASX:EMD) announced the addition of its second clinic in Perth for meeting the increasing demand of patients, while digital health company ResApp Health Limited (ASX:RAP) obtained CE mark certi...

02 Mar 2021 - Digtal health company ResApp Health (ASX:RAP) has achieved CE Mark certification for the company’s wearable device as a Class I medical device accessory.

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AMA)) - Ama Group ((APA)) - APA Group ((APX)) - Appen ((AVG)) - Aust Vintage ((ASG)) - Autosports Group ((BGA)) - Bega Cheese ((BTH)) - Bigtincan Holdings ((BKL)) - Blac...

The Resapp Health Ltd (ASX: RAP) share price spent today in the red after the company’s 1HY21 results came out this morning. Apparently, investors weren’t impressed with the results and sent ResApp shares down 5.0% to close at 5.6 cents a...

The ResApp Health Ltd (ASX: RAP) share price is climbing higher today. This comes after the company provided an update of its prescription-only software application with the United States Food and Drug Administration (FDA). At the time of...

Summary Amid growing adoption of digital platforms, Global Health registered a robust half-year performance. Total customer revenue for the period was up by 20% on PCP. The MasterCare platform for community health care providers exper...

ResApp Health (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, has received a $707,744 R&D tax refund and a $93,994 Export Market Development...

ResApp Health Ltd (ASX: RAP) shares are climbing higher today after the company announced it has launched its SleepCheck app on select Android devices. At the time of writing, the ResApp share price is up 6.25% to 8.5 cents. Quick take on...

Summary ResApp Health launched its SleepCheck app on select Android devices for the risk assessment of sleep apnoea. The app records and analyses breathing and snoring pattern via the smartphone’s microphone for the data collection. R...

Brisbane-based respiratory health company ResApp (ASX:RAP) has launched an Android version of its sleep apnoea-detecting smartphone app, SleepCheck. The company’s ... Read More The post ResApp launches apnoea-detecting SleepCheck app on And...

Summary Global Health Ltd (ASX:GLH) said Lifecard Patient Portal is seeing high demand as health delivery organisations have embraced digital engagement with patients. Lifecard Patient Portal assists consumers and doctors in managing d...

Summary The prominent ASX indices have been rebalanced, effective from 21 December 2020. After the demerger of Iluka Resources from Deterra Royalties, both have been retained in the ASX 200. Afterpay has become one of the 20 most prom...

Summary Only one stock will be removed from the S&P/ASX All Technology Index, while there are thirteen additions.  Australian tech frenzy continues to gain momentum as leaders make all-time highs post rebalance decisions.  S&am...

Summary The intensity of adoption of tech-enabled health solutions has shot up amidst government restrictions and infection risks amidst COVID-19. Burgeoning demand for healthcare products kept healthcare stocks under the spotlight in...

ResApp Health Ltd (ASX: RAP) shares are edging higher today after the company updated the market on its recent meeting with the United States Food and Drug Administration (FDA) for SleepCheck. In the minutes after market open, the ResApp s...

The Resapp Health Ltd (ASX: RAP) share price stormed higher today following the announcement of a new partnership. During afternoon trade, shares in the digital health company reached as high as 9.4 cents, but later pulled back slightly. T...

The ResApp Health Ltd (ASX: RAP) share price is sinking lower today following the company’s release of its quarterly update. At the time of writing, the ResApp share price is down 18.18% to 9 cents. Let’s take a look at why shareholders ar...

The ResApp Health Ltd (ASX: RAP) share price soared higher today following the release of a positive market announcement. During market open, shares in the digital health company surged to an intra-day high of 12 cents. However, a portion...

The Resapp Health Ltd (ASX: RAP) share price has stormed higher today following a positive announcement regarding its software. During mid-afternoon, shares in the digital health company reached an intra-day high of 14 cents. Since then, t...

Summary Digital healthcare service provider ResApp Health Limited announced the signing of a non-exclusive marketing agreement with Australia’s largest consumer healthcare network, HealthEngine. As part of the agreement, HealthEngine&am...

The ResApp Health Ltd (ASX: RAP) share price has surged today following a positive announcement on a partnership agreement. At the time of writing, shares in the digital health company are 10% higher at 11 cents. This compares to the All O...

The ASX200 rose 2.2% in August with technology and consumer discretionary leading the way during the reporting season, while further trading updates are expected during the upcoming AGM season. –The ASX200 climbed 2.2% during August, gainin...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AYS)) – amaysim Australia ((ATL)) – Apollo Tourism & Leisure ((COE)) – Cooper Energy ((EVT)) – Event Hospitality ((GDG)) – Generation Development Group ((IFL)) – IOO...

The ASX200 rose 0.5% in July led by materials, technology and consumer staples; the August reporting season may find companies hesitant to provide guidance amid an uncertain outlook -The ASX200 tottered to a monthly gain of 0.5% in July-The...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week With quart...

ShareCafeHidden Gems Webinar Recap – SWF, OLL, NVU, RAP   We continue to unearth small-cap companies as part of our Hidden Gems webinar series. Catch up on the most recent edition with presentations from Selfwealth Limited (SWF:ASX), Openl...

ShareCafeResapp Health – ShareCafe Hidden Gems Webinar Presentation   Presenter – Tony Keating (CEO) – ResApp Health is developing healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease on sm...

Digital health was the sector du jour for investors around the world in the six months to June 30, with venture capitalists alone sinking $US6.3b ($9.09bn) into the industry. That’s a record figure up 24 per cent on the same period in 2019,...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Victoria h...

The Greens want the current temporary funding system for telehealth made permanent, echoing calls from industry over the last two months. Telehealth has been funded by the Medicare Benefits Scheme (MBS) for a very limited group of people si...

Fortunes were to be made in ASX health stocks during March and April as investors looked for salvation from the COVID-19 pandemic fears rocking markets. However, once the two biggest health stocks Resmed (ASX:RMD) and CSL (ASX:CSL) are take...